The impact of inter partes review on patent litigation
The America Invents Act (AIA) created a new post-grant review proceeding in the USPTO: the inter partes review or IPR. On 16 September, 2012, the USPTO stopped accepting petitions for inter partes re-examination and the IPR took its place.
IPR, like inter partes re-examination before it, allows the USPTO to reconsider the patentability of a patent. There are some key differences between an IPR and prior post-grant proceedings. For an IPR to be instituted, the USPTO must conclude there is ‘a reasonable likelihood that the petitioner would prevail’ in at least one of the claims; a more stringent standard than the old ‘significant new question of patentability’.
An IPR is conducted before the new USPTO Patent Trial and Appeal Board (PTAB), not an examiner, eliminating one layer of proceedings. Invalidity need only be proven by preponderance of the evidence, a lower standard than the federal court ‘clear and convincing’ standard…
If you are registered and logged in to the site, click on the link below to read the rest of the DLA Piper briefing. If not, please register or sign in with your details below.
News from DLA Piper
News from The Lawyer
Briefings from DLA Piper
Cour de Cassation quashes decision that disregarded ICC rule on time limits to arbitrator challenges — two takeaways
This milestone decision further limits the scope for French courts to annul arbitration awards and reinforces the efficiency of France-seated arbitral proceedings.
This decision is in line with a possible judicial trend towards enforceability of good faith obligations under English law.
Analysis from The Lawyer
Shearman & Sterling is making its presence felt in the City, squaring up to magic circle firms and looking to muscle in on key relationships. Private equity house Bridgepoint is one outfit that has had its head turned by the US firm.
A new breed of lawyer is smoothing the path for companies entering emerging or unstable jurisdictions